World News: 10:30 GMT Friday 14th September 2018. [Opthea Limited via Globe Newswire via SPi World News]
MELBOURNE Australia Sept 14 2018 GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a late stage clinical biopharmaceutical company developing first-in-class novel biologic therapies to treat back-of-the-eye diseases announced today that new clini cal dat...
Globe Newswire: 10:30 GMT Friday 14th September 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.